Lymphoproliferative Disorders
|
group |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
300
|
14
|
0.100 |
None |
|
0 |
|
|
|
Hepatomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Finding
|
523
|
30
|
0.100 |
None |
|
0 |
|
|
|
Variable expressivity
|
phenotype |
|
Finding
|
319
|
|
0.100 |
None |
|
0 |
|
|
|
Decreased antibody level in blood
|
phenotype |
|
Finding
|
75
|
5
|
0.100 |
None |
|
0 |
|
|
|
Lymphadenopathy
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
277
|
5
|
0.100 |
None |
|
0 |
|
|
|
Combined immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
86
|
11
|
0.300 |
strong |
1.000 |
1 |
|
2017 |
2017 |
EBV-Related Malignant Neoplasm
|
disease |
|
Neoplastic Process
|
1
|
|
0.300 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Anaplastic astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
202
|
12
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
296
|
9
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Immune thrombocytopenic purpura
|
disease |
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
338
|
35
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Primary immune deficiency disorder
|
group |
Immune System Diseases
|
Disease or Syndrome
|
93
|
23
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Pneumocystis Infections
|
group |
Infections
|
Disease or Syndrome
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
724
|
22
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Low Grade Lymphoma (neoplasm)
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
39
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Squamous cell carcinoma of oropharynx
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
155
|
33
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Solid Neoplasm
|
phenotype |
Neoplasms
|
Neoplastic Process
|
1145
|
24
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
T-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
485
|
24
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Secondary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1370
|
20
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Acute myocardial infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
766
|
118
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Dermatitis, Allergic Contact
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
151
|
1
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Thymic Carcinoma
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
82
|
8
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
gliosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
80
|
5
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Anaplastic thyroid carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
392
|
16
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |